NewAmsterdam Pharma Company N.V.
← Back to NAMSW Overview

NewAmsterdam Pharma Company N.V. (NAMSW)

Profitability & Net Margin History

Current Net Margin

-234134.38%

NewAmsterdam Pharma Company N.V. currently has a net profit margin of -234134.38%. Net margin is a key efficiency ratio that measures what percentage of each dollar of revenue actually results in profit for the company.

Historical Margin Data

Quarterly and annual profitability trends

DateRevenue ($B)Net Income ($B)Net MarginChange (bps)
2025-12-310.00-0.07-234134.38%21344328
2025-09-300.00-0.07-20691.09%2060039
2025-06-300.02-0.02-90.70%123660
2025-03-310.00-0.04-1327.30%60559
2024-12-310.01-0.09-721.71%66453
2024-09-300.03-0.02-57.18%165440
2024-06-300.00-0.04-1711.58%498128
2024-03-310.00-0.09-6692.86%52910
2023-12-310.00-0.05-6163.76%456114
2023-09-300.00-0.05-1602.62%62749
2023-06-300.00-0.04-2230.11%174317
2023-03-310.01-0.04-486.94%20419
2022-12-310.01-0.04-691.13%0
2022-09-300.01-0.04-691.13%74943
2022-06-300.050.0358.30%0
2022-03-310.050.0358.30%
2021-12-31-0.02
2021-09-30-0.01
2021-06-30-0.01
2021-03-31-0.01
2020-12-310.00
2020-09-30-0.00
2020-06-30-0.00
2020-03-31-0.00

* Net margin = (Net Income / Total Revenue) * 100. Based on official SEC filings.